Profession Notes

Tools of the Trade As knowledge advances regarding deadly diseases and subsequent treatments, many scientists are relying on the tools and techniques being developed by biotechnology companies to achieve research goals. One genomic information company, Incyte Genomics of Palo Alto, Calif., recently launched Incyte.com, a genomics Web site with proprietary human gene as well as public domain sequence information. The company is focused on the discovery and analysis of genes as they are expressed

Kate Devine
Sep 3, 2000

Tools of the Trade

As knowledge advances regarding deadly diseases and subsequent treatments, many scientists are relying on the tools and techniques being developed by biotechnology companies to achieve research goals. One genomic information company, Incyte Genomics of Palo Alto, Calif., recently launched Incyte.com, a genomics Web site with proprietary human gene as well as public domain sequence information. The company is focused on the discovery and analysis of genes as they are expressed in healthy and diseased tissues--that is, the 3 percent-5 percent of the human genome that are transcribed genes. Randy Scott, president and chief scientific officer, says, "Genomic data and technologies are already beginning to have a dramatic impact on development of new drugs and diagnostic tests, as well as improvement of drug efficacy and safety." Incyte says it has the world's largest database of transcribed genes, and that it is the top commercial holder...